Need help now? Free crisis lines and helplines, worldwide — chapter 02 →
0 results for

Sleep — Insomnia Treatment, Sleep Apnoea & Sleep Health

Category 11 of 20 in chapter 17, The Research Behind It, of Notbroken's Free Metabolic & Mental Health Help Directory: 14 listings, each carefully picked (listed, not endorsed). All 280 listings in The Research Behind It · Open the full directory of 2299 listings.
14
Listings
11 / 20
Category
17 / 18
Chapter
Latest Edition Always download the most up-to-date version, free, at notbroken.io
Know someone who could benefit? Share this guide with them.
Free to use · No account needed
Navigation
Contents
17
The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows
THE EVIDENCE
THE EVIDENCE

The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows

Why would a support group, a walking club, a low-carb book or an online CBT course help — and what drives chronic illness in the first place? This chapter gathers the research behind each part of the directory, and the research on causes: metabolic therapies, the nutrients in food, plastics and pollution, stress and trauma, the microbiome, and damp and mould. That is 280 studies, reviews and clinical guidelines, every one free to read and download in full, permanently and without a login. Most are kept in PubMed Central, the US National Library of Medicine's public archive; the rest are open access at the publisher, or free guidance from the World Health Organization and NICE. Each entry says what was found, why it matters here — which listings it backs up, or what it explains about chronic disease — and how strong the evidence is: strong (systematic reviews and guidelines with consistent findings), moderate (smaller or lower-certainty reviews, single large trials and large cohort studies) or early (pilot, cross-sectional and laboratory studies — promising, not proof). Studies that follow people over time show links, not proof of cause, and the entries say so. Where a study was funded by a company, or its authors run a listed programme, the note says so; where a listed book or service was not itself tested, the entry says it backs the approach rather than the product. Research moves on, so read these as good reasons to try something, not guarantees — and talk to your own clinician before changing a treatment or a medicine. Every paper was checked at least twice: by the researcher who chose it and again, independently, against its abstract and full text (the first 186 a third time); its public record was checked for corrections, retractions and expressions of concern (none is retracted), every number was looked up in the full text, and every link was opened in a browser.

Sleep — Insomnia Treatment, Sleep Apnoea & Sleep Health

Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline — Edinger et al., J Clin Sleep Med 2021

Clinical practice guideline (GRADE) built on a systematic review and meta-analyses — 66 randomised trials of CBT-I identified, 49 pooled. Strong evidence. J Clin Sleep Med 2021;17(2):255–262. DOI 10.5664/jcsm.8986. Free full text in PubMed Central (PMC7853203). Note: The CBT-I recommendation rests mainly on trials of therapist-delivered CBT-I; the panel found too little evidence to recommend particular formats such as online programmes or self-help books.
What It Found
The American Academy of Sleep Medicine graded the randomised-trial evidence for non-drug insomnia treatments. It strongly recommends multicomponent cognitive behavioural therapy for insomnia (CBT-I) for adults with chronic insomnia; gives conditional recommendations for brief behavioural therapy, stimulus control, sleep restriction and relaxation; and suggests not using sleep-hygiene advice on its own.
Why It Matters Here
Backs up the CBT-I therapist directories in chapter 11, since the strong recommendation rests mainly on CBT-I given by trained professionals. It found too little evidence to recommend particular formats, so the online programmes and apps in chapter 11 and the books and guides in chapter 10 are supported less directly.
Clinical practice guideline (GRADE) built on a systematic review and meta-analyses — 66 randomised trials of CBT-I identified, 49 pooled. Strong evidence. J Clin Sleep Med 2021;17(2):255–262. DOI 10.5664/jcsm.8986. Free full text in PubMed Central (PMC7853203). Note: The CBT-I recommendation rests mainly on trials of therapist-delivered CBT-I; the panel found too little evidence to recommend particular formats such as online programmes or self-help books.

The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 — Riemann et al., J Sleep Res 2023

Clinical practice guideline by a European expert group, based on systematic and meta-analytic reviews, with graded (A–C) recommendations. Strong evidence. J Sleep Res 2023;32(6):e14035. Free full text at the publisher — open access, CC BY 4.0.
What It Found
European insomnia experts updated the European insomnia guideline. Its first-line recommendation (grade A) is CBT-I for adults of any age with chronic insomnia, including people with other physical or mental illnesses, delivered face to face or digitally. Medicines are for when CBT-I is not effective enough; it advises against antihistamines, antipsychotics, fast-release melatonin and herbal remedies for insomnia.
Why It Matters Here
Backs up the CBT-I therapists, digital CBT-I programmes and sleep clinics in chapter 11 and the CBT-I books and NHS inform guide in chapter 10; also tells readers of the natural-therapy listings in chapter 11 that herbal sleep remedies are not recommended.
Clinical practice guideline by a European expert group, based on systematic and meta-analytic reviews, with graded (A–C) recommendations. Strong evidence. J Sleep Res 2023;32(6):e14035. Free full text at the publisher — open access, CC BY 4.0.

Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-Analysis — Furukawa et al., JAMA Psychiatry 2024

Systematic review and component network meta-analysis — 241 randomised trials, 31,452 adults. Moderate evidence. JAMA Psychiatry 2024;81(4):357–365. DOI 10.1001/jamapsychiatry.2023.5060. Free full text in PubMed Central (PMC10794978) — open access, CC BY. Note: The authors call the component results hypothesis-generating: they rest on indirect comparisons, assume the parts simply add up, and certainty was moderate to low.
What It Found
Pooled 241 trials to see which parts of CBT-I matter. Cognitive restructuring (incremental odds ratio for remission 1.68), mindfulness/acceptance (1.49), sleep restriction (1.49) and stimulus control (1.43) helped; sleep-hygiene education (1.01) added nothing and relaxation (0.81) may be counterproductive. In-person therapist delivery helped most (1.83). Versus in-person sleep education, the four helpful parts given in person meant one extra remission per three treated.
Why It Matters Here
Backs up the CBT-I therapists and programmes in chapter 11 and the CBT-I books in chapter 10. Its finding that mindfulness and acceptance parts added to CBT-I helped is relevant to The Sleep Book's approach, though that book was not tested. Useful for checking a programme includes the techniques that carry the effect.
Systematic review and component network meta-analysis — 241 randomised trials, 31,452 adults. Moderate evidence. JAMA Psychiatry 2024;81(4):357–365. DOI 10.1001/jamapsychiatry.2023.5060. Free full text in PubMed Central (PMC10794978) — open access, CC BY. Note: The authors call the component results hypothesis-generating: they rest on indirect comparisons, assume the parts simply add up, and certainty was moderate to low.

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial — Kyle et al., Lancet 2023

Pragmatic randomised controlled trial — 642 adults with insomnia disorder in 35 English general practices. Moderate evidence. Lancet 2023;402(10406):975–987. Free full text at the publisher — open access, CC BY 4.0. Note: Open-label trial with self-reported outcomes; the comparison was a booklet rather than another active therapy.
What It Found
Practice nurses gave four brief sessions of sleep restriction therapy (a core part of CBT-I) plus a sleep-hygiene booklet, compared with the booklet alone. At 6 months insomnia severity was clearly lower with sleep restriction (Insomnia Severity Index 10.9 vs 13.9; difference −3.05, 95% CI −3.83 to −2.28; d = −0.74), and it was likely cost-effective for the NHS (£2,076 per quality-adjusted life year).
Why It Matters Here
Backs up brief behavioural treatment for insomnia through ordinary health services, the sleep-restriction step taught in the CBT-I books and NHS inform guide in chapter 10, and the CBT-I programmes in chapter 11; relevant to people who cannot get full CBT-I.
Pragmatic randomised controlled trial — 642 adults with insomnia disorder in 35 English general practices. Moderate evidence. Lancet 2023;402(10406):975–987. Free full text at the publisher — open access, CC BY 4.0. Note: Open-label trial with self-reported outcomes; the comparison was a booklet rather than another active therapy.

Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial — Espie et al., JAMA Psychiatry 2019

Randomised controlled trial (DIALS) — 1,711 adults with insomnia, run online. Moderate evidence. JAMA Psychiatry 2019;76(1):21–30. DOI 10.1001/jamapsychiatry.2018.2745. Free full text in PubMed Central (PMC6583463). Note: Funded by Big Health, which makes Sleepio and helped design and run the trial; the lead author co-founded the company. Participants were mostly white (91%) and female (78%).
What It Found
Adults with insomnia were randomised to Sleepio, a fully automated six-session digital CBT-I course, or online sleep-hygiene education, both on top of usual care. At 24 weeks the Sleepio group had small gains in day-to-day functional health (d = 0.31) and psychological well-being (d = 0.38), a large gain in sleep-related quality of life (d = 1.46) and much less insomnia (d = 1.51); better sleep accounted for 46–84% of these gains.
Why It Matters Here
Backs up Sleepio in chapter 11 directly. For the other digital CBT-I courses and apps there (Sleepstation, THIS WAY UP, VA Insomnia Coach) and the CBT-I books in chapter 10 it supports the approach, not those products. Relevant to people who cannot reach a CBT-I therapist.
Randomised controlled trial (DIALS) — 1,711 adults with insomnia, run online. Moderate evidence. JAMA Psychiatry 2019;76(1):21–30. DOI 10.1001/jamapsychiatry.2018.2745. Free full text in PubMed Central (PMC6583463). Note: Funded by Big Health, which makes Sleepio and helped design and run the trial; the lead author co-founded the company. Participants were mostly white (91%) and female (78%).

The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis — Freeman et al., Lancet Psychiatry 2017

Randomised controlled trial — 3,755 university students with insomnia at 26 UK universities. Moderate evidence. Lancet Psychiatry 2017;4(10):749–758. DOI 10.1016/S2215-0366(17)30328-0. Free full text in PubMed Central (PMC5614772) — open access, CC BY 4.0. Note: About half dropped out (more with Sleepio), outcomes were self-reported, and manic symptoms rose slightly with treatment. Two authors worked for Big Health, which makes Sleepio.
What It Found
Students with insomnia were randomised to Sleepio, a six-session digital CBT-I course, or usual care. At 10 weeks insomnia had improved markedly (d = 1.11), with small falls in paranoia (d = 0.19) and hallucinatory experiences (d = 0.24) and less depression (d = 0.48) and anxiety (d = 0.33). Better sleep accounted for about 58% of the fall in paranoia and 39% of that in hallucinations, which the authors take as evidence that poor sleep contributes to mental-health problems.
Why It Matters Here
Backs up Sleepio and the approach of the other online CBT-I programmes in chapter 11 and the CBT-I books in chapter 10 as a low-cost first step that can also ease low mood and anxiety; most relevant to students and young adults.
Randomised controlled trial — 3,755 university students with insomnia at 26 UK universities. Moderate evidence. Lancet Psychiatry 2017;4(10):749–758. DOI 10.1016/S2215-0366(17)30328-0. Free full text in PubMed Central (PMC5614772) — open access, CC BY 4.0. Note: About half dropped out (more with Sleepio), outcomes were self-reported, and manic symptoms rose slightly with treatment. Two authors worked for Big Health, which makes Sleepio.

Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials — Scott et al., Sleep Med Rev 2021

Systematic review and meta-analysis — 65 randomised trials (72 interventions), 8,608 participants. Moderate evidence. Sleep Med Rev 2021;60:101556. DOI 10.1016/j.smrv.2021.101556. Free full text in PubMed Central (PMC8651630) — open access, CC BY. Note: Only trials that had already improved sleep were included; results varied widely (I² = 76%), and the mental-health gain was much smaller at 6 months or more (g = −0.18).
What It Found
Pooled 65 randomised trials in which a sleep treatment, mostly CBT-I, measurably improved sleep, then looked at mental health. Better sleep led to medium-sized gains in overall mental health (g = −0.53), depression (−0.63), anxiety (−0.51) and rumination (−0.49), and smaller gains for stress (−0.42) and positive psychotic symptoms (−0.26). The bigger the sleep improvement, the bigger the mental-health gain.
Why It Matters Here
Backs up the CBT-I programmes, therapists and books in chapters 10 and 11 as a route to better mental health as well as better sleep; especially relevant to people with depression or anxiety whose sleep is poor.
Systematic review and meta-analysis — 65 randomised trials (72 interventions), 8,608 participants. Moderate evidence. Sleep Med Rev 2021;60:101556. DOI 10.1016/j.smrv.2021.101556. Free full text in PubMed Central (PMC8651630) — open access, CC BY. Note: Only trials that had already improved sleep were included; results varied widely (I² = 76%), and the mental-health gain was much smaller at 6 months or more (g = −0.18).

Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis — Hertenstein et al., Sleep Med Rev 2022

Systematic review and meta-analysis — 22 randomised trials in adults with a mental disorder and insomnia. Moderate evidence. Sleep Med Rev 2022;62:101597. Free full text at the publisher — open access, CC BY-NC-ND 4.0. Note: Few, small trials for bipolar disorder and psychosis; benefits for the mental disorder itself were not significant at later follow-up.
What It Found
Pooled 22 randomised trials of CBT-I for people whose insomnia sits alongside depression, PTSD, alcohol dependence, bipolar disorder, psychosis or mixed diagnoses. Insomnia improved with medium-to-large effects (effect size 0.5 in depression, 1.5 in PTSD, 1.4 in alcohol dependence), and depression (0.5) and PTSD (1.3) symptoms also eased after treatment. The authors suggest CBT-I as a first-line insomnia treatment in this group.
Why It Matters Here
Backs up the CBT-I providers in chapter 11 and the approach of the Carney & Manber workbook (insomnia with depression, anxiety or pain) in chapter 10; most relevant to people whose insomnia comes with a mental-health condition, and to therapists in chapter 05 who offer CBT-I.
Systematic review and meta-analysis — 22 randomised trials in adults with a mental disorder and insomnia. Moderate evidence. Sleep Med Rev 2022;62:101597. Free full text at the publisher — open access, CC BY-NC-ND 4.0. Note: Few, small trials for bipolar disorder and psychosis; benefits for the mental disorder itself were not significant at later follow-up.

Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial — Irwin et al., JAMA Psychiatry 2022

Randomised controlled trial — 291 adults aged 60 or over with insomnia and no current depression, followed for 3 years. Moderate evidence. JAMA Psychiatry 2022;79(1):33–41. DOI 10.1001/jamapsychiatry.2021.3422. Free full text in PubMed Central (PMC8733847) — open access, CC BY 4.0. Note: A single US site with a mostly white sample; only about half had 3-year data, and more people dropped out of the CBT-I group in the first two years.
What It Found
Older adults with insomnia but no current depression had two months of weekly group CBT-I or group sleep education. Over three years, 12.2% of the CBT-I group developed major depression versus 25.9% of the education group (hazard ratio 0.51, 95% CI 0.29–0.88); about seven people needed CBT-I to prevent one case. Those whose insomnia stayed in remission had the lowest risk.
Why It Matters Here
Backs up the CBT-I therapists in chapter 11 (the trial used psychologist-led group CBT-I) as a way to protect mood, not only sleep, and the CBT-I books in chapter 10 less directly; most relevant to older adults, and to therapists in chapter 05 who offer CBT-I.
Randomised controlled trial — 291 adults aged 60 or over with insomnia and no current depression, followed for 3 years. Moderate evidence. JAMA Psychiatry 2022;79(1):33–41. DOI 10.1001/jamapsychiatry.2021.3422. Free full text in PubMed Central (PMC8733847) — open access, CC BY 4.0. Note: A single US site with a mostly white sample; only about half had 3-year data, and more people dropped out of the CBT-I group in the first two years.

The Consensus Sleep Diary: Standardizing Prospective Sleep Self-Monitoring — Carney et al., Sleep 2012

Expert consensus and patient focus-group development study. Moderate evidence. Sleep 2012;35(2):287–302. DOI 10.5665/sleep.1642. Free full text in PubMed Central (PMC3250369). Note: Describes how the diary was designed; it is a measuring tool, not a treatment, and this paper did not test whether keeping it improves sleep.
What It Found
Explains how the standard sleep diary used in insomnia research and CBT-I was built. Diaries from 25 experts at a sleep assessment conference were collected and an expert committee condensed them into a core diary; six focus groups of good sleepers, people with insomnia and people with sleep apnoea refined the wording, and another group checked the draft. The core diary needs only a US third-grade reading level. The authors call it a living document still needing validation.
Why It Matters Here
Backs up the Consensus Sleep Diary listing in chapter 10 (this paper describes the diary behind the free app and PDF) and the sleep-diary step built into the CBT-I programmes and apps in chapter 11; useful for anyone starting CBT-I or preparing for a sleep-clinic appointment.
Expert consensus and patient focus-group development study. Moderate evidence. Sleep 2012;35(2):287–302. DOI 10.5665/sleep.1642. Free full text in PubMed Central (PMC3250369). Note: Describes how the diary was designed; it is a measuring tool, not a treatment, and this paper did not test whether keeping it improves sleep.

Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline — Patil et al., J Clin Sleep Med 2019

Clinical practice guideline (GRADE) built on a systematic review and meta-analyses of randomised trials. Strong evidence. J Clin Sleep Med 2019;15(2):335–343. DOI 10.5664/jcsm.7640. Free full text in PubMed Central (PMC6374094).
What It Found
The American Academy of Sleep Medicine reviewed the trials of CPAP and other positive airway pressure (PAP) machines. It strongly recommends PAP for adults with obstructive sleep apnoea who are excessively sleepy (38 trials), suggests it for poor sleep-related quality of life and high blood pressure, and strongly recommends education when starting PAP, with behavioural, troubleshooting and telemonitoring support suggested to help people keep using it.
Why It Matters Here
Backs up the sleep-clinic finders in chapter 11, where sleep apnoea is diagnosed and PAP is started, and the CPAP education offered by the patient organisations there. Its education and support advice is about clinic care; it did not test peer support. Most relevant to people newly diagnosed with sleep apnoea.
Clinical practice guideline (GRADE) built on a systematic review and meta-analyses of randomised trials. Strong evidence. J Clin Sleep Med 2019;15(2):335–343. DOI 10.5664/jcsm.7640. Free full text in PubMed Central (PMC6374094).

Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea — Askland et al., Cochrane Database Syst Rev 2020

Cochrane systematic review and meta-analysis — 41 randomised trials, 9,005 adults. Strong evidence. Cochrane Database Syst Rev 2020;4:CD007736. DOI 10.1002/14651858.CD007736.pub3. Free full text in PubMed Central (PMC7137251). Note: Over half the trials had a high risk of bias, peer-led support was not assessed as a separate category, and effects on sleepiness and quality of life were uncertain.
What It Found
Reviewed 41 trials of ways to help people with sleep apnoea keep using CPAP. Behavioural approaches such as motivational support raised use by about 1.3 hours a night (95% CI 0.95 to 1.66; high-certainty evidence) and helped more people reach 4+ hours a night; ongoing supportive help such as follow-up contact added about 0.7 hours (moderate certainty). Evidence for education alone was very low certainty.
Why It Matters Here
Backs up the idea behind the CPAP support listings in chapter 11 (the AWAKE peer-mentor programme, Hope2Sleep, Apnea Board): ongoing support and motivation help people keep using CPAP, although these services themselves were not tested. Relevant to anyone struggling to get used to CPAP.
Cochrane systematic review and meta-analysis — 41 randomised trials, 9,005 adults. Strong evidence. Cochrane Database Syst Rev 2020;4:CD007736. DOI 10.1002/14651858.CD007736.pub3. Free full text in PubMed Central (PMC7137251). Note: Over half the trials had a high risk of bias, peer-led support was not assessed as a separate category, and effects on sleepiness and quality of life were uncertain.

A Pilot Study of CPAP Adherence Promotion by Peer Buddies with Sleep Apnea — Parthasarathy et al., J Clin Sleep Med 2013

Randomised controlled pilot trial — 39 newly diagnosed patients, with 13 experienced CPAP users as peer buddies. Early evidence. J Clin Sleep Med 2013;9(6):543–550. DOI 10.5664/jcsm.2744. Free full text in PubMed Central (PMC3659373). Note: A small single-centre pilot; a larger trial is needed before peer buddies can be said to improve CPAP use.
What It Found
Newly diagnosed people with obstructive sleep apnoea were randomised to be paired with an experienced CPAP user (a 'peer buddy') or to usual care. Over the first 90 days, weekly CPAP use was higher in the peer-buddy group (p = 0.04), and 91% rated the buddy system satisfactory or very satisfactory. There were no differences in daytime functioning, vigilance or self-efficacy.
Why It Matters Here
Backs up, as early evidence, the one-to-one CPAP peer mentoring in chapter 11 (the AWAKE peer-mentor programme), and more loosely the patient-led apnoea support there (Hope2Sleep, Apnea Board, Project Sleep's Sleep Apnea Squad); most relevant to people starting CPAP.
Randomised controlled pilot trial — 39 newly diagnosed patients, with 13 experienced CPAP users as peer buddies. Early evidence. J Clin Sleep Med 2013;9(6):543–550. DOI 10.5664/jcsm.2744. Free full text in PubMed Central (PMC3659373). Note: A small single-centre pilot; a larger trial is needed before peer buddies can be said to improve CPAP use.

Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline — Winkelman et al., J Clin Sleep Med 2025

Clinical practice guideline (GRADE) based on a systematic review of treatment trials. Strong evidence. J Clin Sleep Med 2025;21(1):137–152. DOI 10.5664/jcsm.11390. Free full text in PubMed Central (PMC11701286). Note: Over half the recommendations are conditional and rest on low- or very-low-certainty evidence; it comes from a US professional body.
What It Found
The American Academy of Sleep Medicine's updated guideline for restless legs syndrome. It advises regular iron checks and dealing first with triggers such as alcohol, caffeine, some medicines and untreated sleep apnoea. It strongly recommends gabapentinoid medicines, and intravenous ferric carboxymaltose when iron is below RLS-specific levels. It suggests against standard use of dopamine-type medicines, because of worsening over time (augmentation), and against valerian.
Why It Matters Here
Backs up the treatment information from the Restless Legs Syndrome Foundation (and its Quality Care Centers) and the RLS-UK/EARLS community in chapter 11, and the sleep-clinic finders there; it does not test these services. Most relevant to people with RLS reviewing a long-standing treatment.
Clinical practice guideline (GRADE) based on a systematic review of treatment trials. Strong evidence. J Clin Sleep Med 2025;21(1):137–152. DOI 10.5664/jcsm.11390. Free full text in PubMed Central (PMC11701286). Note: Over half the recommendations are conditional and rest on low- or very-low-certainty evidence; it comes from a US professional body.
Important Disclaimer
This directory is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your medication regimen or starting any new therapy.

This document does not guarantee the legitimacy, quality, or suitability of any business, organization, or practitioner listed within. The inclusion of any listing does not constitute an endorsement, recommendation, or verification of credentials. All organizations listed are independent entities over which the creators of this directory have no control or oversight.

This directory is intended to be used as a starting point and reference for the reader to conduct their own research, exercise their own judgment, and apply their own discretion before engaging with any listed organization or professional. Readers are strongly encouraged to independently verify credentials, read reviews, check licensing, and confirm current pricing and availability directly with each organization before committing to any services.

Costs, availability, contact details, and services may change at any time without notice. Information was accurate to the best of our knowledge at the time of publication.

About Notbroken.io: this directory and the accompanying Breathe, Calm, Sleep, Move, Eat, Track and Build tools were created by Nathan Leary, who runs and updates them. How each tool works, its safety notes, the privacy policy and terms of use are at notbroken.io/about, notbroken.io/privacy and notbroken.io/terms. The tools are general wellness aids, not medical devices, and Track is a personal journal that never gives medication advice.

If you are in crisis: Please contact your local emergency services immediately, or reach out to one of the following helplines:

International: Chapter 02 of this directory lists free helplines by situation and country; elsewhere use Find A Helpline — findahelpline.com
United States: 988 Suicide & Crisis Lifeline (call or text 988) • Crisis Text Line (text HOME to 741741)
United Kingdom: Samaritans — 116 123 (free, 24/7)
Canada: Talk Suicide Canada — 988 (call or text, 24/7)
Australia: Lifeline — 13 11 14 (24/7) • Beyond Blue — 1300 22 4636
New Zealand: Need to Talk? — 1737 (free, 24/7)
Europe: European Emergency Number — 112
India: iCall — 9152987821 • Vandrevala Foundation — 1860 2662 345
Singapore: Samaritans of Singapore — 1-767 (24/7)
Japan: TELL Lifeline — 03-5774-0992

No matches found

Nothing matched . Try broadening your search — remove a filter, use a single keyword, describe what you need in a sentence, or browse by a condition, a place, or a type of support.

Suggest a resource